Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Bioversys AG and Aptuit have announced the start of a joint collaboration aimed at the identification and validation of novel targets and molecules for Gram-negative bacteria. Aptuit and BioVersys hope that innovative approaches can address ...
read more
Velocity Clinical Research has announced a strategic partnership with Palantir Technologies to automate and streamline the notoriously complex payments reconciliation process in clinical trials. This collaboration marks a milestone in applying ...
read more
The Thermo Scientific Smart-Vue Pro Wireless Monitoring Solution provides real-time, continuous monitoring of critical laboratory equipment parameters and immediately notifies users about off-limit measurements that, if left unattended, could ...
read more
Thursday, November 20, 2014
SGS Life Science Services, the leading pharmaceutical analytical and bioanalytical contract solutions provider, today announced that it is to bring added-value to French clients’ drug development activities, as SGS’ biologics testing laboratory in ...
read more
Wednesday, August 04, 2021
WuXi STA announced that it has completed the acquisition of a drug product manufacturing facility in Couvet, Switzerland from Bristol Myers Squibb. WuXi STA first announced its plans to purchase the facility earlier this year. The acquisition will ...
read more
Northwest Biotherapeutics and Advent BioServices, a leading contract development and manufacturing organization (CDMO) based in the UK, jointly announce that a MIA license has been approved and issued by the Medicines and Healthcare Products ...
read more
Enzene announced that ahead of the official opening of its biologics manufacturing facility in Hopewell, close to Princeton in New Jersey, it has expanded its plans for the site.
read more
Thursday, August 16, 2018
LakePharma has successfully completed moving and consolidating all of its antibody services at its new location at 201 Industrial Rd., San Carlos, CA.
read more
Thursday, November 10, 2016
Bionical, an integrated outsourced specialist to the pharmaceutical, biotechnology and public health industry, announced the strategic acquisition of Emas Pharma (Emas), a global Clinical Research Organization.
read more
Key Biologics and Astarte Biologics announced the launch of an IRB-approved initiative to support the research, therapeutic, and vaccine communities with access to blood products collected from COVID-19 convalescent donors.
read more
Abveris announced the release of antibody sequences specific to the SARS-CoV-2 spike (S) protein into the public domain for unrestricted use.
read more
PPD and Acurian announced a new patient concierge service designed to make it easier for patients to participate in clinical trials and help pharmaceutical and biotechnology clients retain patients.
read more
Wednesday, February 22, 2023
The development of a new enzyme for double strand oligonucleotide formation with high productivity has been announced by Ajinomoto Bio-Pharma Services, a leading provider of biopharmaceutical contract development and manufacturing services.
read more
Acentrus Specialty has signed a strategic agreement with LicenseLogix to provide license compliance services to Acentrus clients.
read more
Rentschler obtained the certificate of GMP compliance and the pharmaceutical manufacturing license for the European market from the Austrian Agency for Health and Food Safety.
read more